United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
569.11
+2.12 (0.37%)
Apr 28, 2026, 4:00 PM EDT - Market closed
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tyvaso | 1.88B | 1.83B | 1.79B | 1.71B | 1.62B | 1.56B | 1.45B | 1.37B | ||||||||||||||
| Tyvaso Growth | 15.91% | 17.66% | 23.39% | 25.33% | 31.34% | 38.18% | 36.87% | 45.60% | ||||||||||||||
| Remodulin | 526.80M | 533.30M | 535.70M | 548.30M | 538.10M | 518.70M | 521.50M | 501.40M | ||||||||||||||
| Remodulin Growth | -2.10% | 2.81% | 2.72% | 9.35% | 8.75% | 3.29% | 7.50% | 2.35% | ||||||||||||||
| Orenitram | 496.90M | 483.50M | 465.60M | 448.80M | 434.30M | 410.60M | 389.40M | 377.40M | ||||||||||||||
| Orenitram Growth | 14.41% | 17.75% | 19.57% | 18.92% | 20.84% | 16.95% | 12.35% | 14.19% | ||||||||||||||
| Unituxin | 226.80M | 232.00M | 245.20M | 238.50M | 238.70M | 225.40M | 215.60M | 208.20M | ||||||||||||||
| Unituxin Growth | -4.99% | 2.93% | 13.73% | 14.55% | 20.01% | 24.26% | 22.36% | 18.03% | ||||||||||||||
| Adcirca | 30.00M | 26.90M | 24.20M | 23.40M | 23.80M | 25.90M | 26.20M | 28.00M | ||||||||||||||
| Adcirca Growth | 26.05% | 3.86% | -7.63% | -16.43% | -17.65% | -20.31% | -27.02% | -27.84% | ||||||||||||||
| Other | 24.00M | 22.90M | 21.50M | 20.90M | 22.10M | 20.50M | 16.90M | 12.00M | ||||||||||||||
| Other Growth | 8.60% | 11.71% | 27.22% | 74.17% | 166.27% | 150.00% | - | 90.48% |
Revenue by Geography
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 752.80M | 774.80M | 759.80M | 749.60M | 705.70M | 717.30M | 675.20M | 641.50M | ||||||||||||||
| United States Growth | 6.67% | 8.02% | 12.53% | 16.85% | 20.45% | 22.70% | 20.14% | 36.58% | ||||||||||||||
| International | 145.70M | 138.50M | 145.40M | 146.30M | 137.70M | 136.30M | 129.50M | 124.30M | ||||||||||||||
| International Growth | 5.81% | 1.61% | 12.28% | 17.70% | 9.90% | 9.65% | 12.32% | 15.84% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.